Agent used for treatment of heparin induced thrombocytopenia –
**Core Concept**
Heparin-induced thrombocytopenia (HIT) is a serious immune-mediated disorder caused by the formation of antibodies against the complex of heparin and platelet factor 4 (PF4), leading to platelet activation, aggregation, and thrombocytopenia. The treatment of HIT requires the use of alternative anticoagulants that do not cross-react with the HIT antibodies.
**Why the Correct Answer is Right**
The treatment of HIT involves the use of direct thrombin inhibitors, which can be used to prevent further thrombosis and are not affected by the HIT antibodies. Fondaparinux, a synthetic pentasaccharide, is also used as an alternative to heparin in patients with HIT. However, the most commonly used agent for treating HIT is a direct thrombin inhibitor, specifically Argatroban. Argatroban is a small-molecule direct thrombin inhibitor that is administered intravenously and is effective in preventing and treating thrombosis in patients with HIT.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a direct thrombin inhibitor, which is the preferred treatment for HIT. While heparin is often used as a diagnostic tool to confirm HIT, it is contraindicated in patients with a confirmed diagnosis of HIT.
**Option B:** This option is incorrect because while warfarin is an anticoagulant, it is not suitable for use in patients with HIT. Warfarin can actually worsen the condition by enhancing the formation of thrombin-antithrombin complexes, which can further activate the coagulation cascade.
**Option C:** This option is incorrect because platelet transfusions are not a recommended treatment for HIT. In fact, platelet transfusions can actually worsen the condition by increasing the risk of thrombosis.
**Clinical Pearl / High-Yield Fact**
In patients with HIT, it is essential to discontinue all forms of heparin, including low molecular weight heparin and heparin flushes, and to initiate treatment with a direct thrombin inhibitor, such as Argatroban. This can help prevent further thrombosis and improve patient outcomes.
**Correct Answer: C. Argatroban**